EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils

Hina Lateef Nizami, Krishnamoorthy Srinivasan, Shyam Sunder Sharma

Indian Journal of Pharmacology · 2025

DOI: 10.4103/ijp.ijp_726_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmacology, 2025. Verfasst von Hina Lateef Nizami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Molecular Neuropharmacology Laboratory, National Institute of Pharmaceutical Education and Research, Sahib…. Hauptthemen laut MEDLINE: Imatinib Mesylate, Brain Ischemia, Neuroprotective Agents, Hippocampus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imatinib mesylate, a selective tyrosine kinase inhibitor, exhibited beneficial effects against various neurological diseases besides its anticancer activity. However, its effects on global cerebral ischemia in gerbils remain to be investigated. Global cerebral ischemia was induced by bilateral carotid artery occlusion (BCAO) in male Mongolian gerbils. Imatinib (3, 10, and 30 mg/kg BW) was administered intraperitoneally (i.p.) 30 min before BCAO. Imatinib (3 and 10 mg/kg) significantly ameliorated neurological deficits, locomotor hyperactivity, and cognitive deficits (Y-maze spontaneous alternations) at 4, 24, and 72 h, respectively, after reperfusion in gerbils. Imatinib caused reduction in neuronal cell death in CA1 hippocampal region of gerbils after BCAO and was associated with abrogation of elevated immunoreactivity of endoplasmic reticulum (ER) stress markers (GRP78 and CHOP). This study demonstrates the neuroprotective effect along with functional improvement by imatinib in global cerebral ischemia in gerbils that may be due to mitigation of ER stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imatinib MesylateBrain IschemiaNeuroprotective AgentsHippocampusNeuronsBehavior, AnimalAnimalsGerbillinaeMaleEndoplasmic Reticulum StressMaze Learning

Stichwörter der Autor:innen

Endoplasmic reticulum stressglobal cerebral ischemiaimatinibneurobehavioral deficitneuronal damageneuroprotection

Substanzen

Imatinib MesylateNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Molecular Neuropharmacology Laboratory, National Institute of Pharmaceutical Education and Research, Sahibzada Ajit Singh Nagar, Punjab, India.
  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.

Zitieren

APA

Nizami, H. L., Srinivasan, K., & Sharma, S. S. (2025). Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_726_23

Vancouver

Nizami HL, Srinivasan K, Sharma SS. Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils. Indian Journal of Pharmacology. 2025. doi:10.4103/ijp.ijp_726_23

BibTeX
@article{Nizami2025,
  author = {Nizami, Hina Lateef and Srinivasan, Krishnamoorthy and Sharma, Shyam Sunder},
  title = {Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils},
  journal = {Indian Journal of Pharmacology},
  year = {2025},
  doi = {10.4103/ijp.ijp_726_23}
}
Kostenlos starten →